<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 48-year-old man with respiratory discomfort was diagnosed with <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> with carcinomatous lymphangiosis, together with lung and sternum <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>As the patient's performance status(PS) was 2, mFOLFOX6+bevacizumab (Bmab)therapy with a 20% reduction in the dose was started </plain></SENT>
<SENT sid="2" pm="."><plain>Three courses of this treatment resulted in improved respiratory function, and his PS dropped to 1 </plain></SENT>
<SENT sid="3" pm="."><plain>A chest computed tomography(CT) scan taken after four courses of this treatment indicated that <z:hpo ids='HP_0002202'>pleural effusion</z:hpo> had almost disappeared, and that the shadow on the lung had also reduced </plain></SENT>
<SENT sid="4" pm="."><plain>However, after 20 courses of this treatment the disease had progressed </plain></SENT>
<SENT sid="5" pm="."><plain>The regimen was changed to irinotecan (<z:chebi fb="9" ids="27656">CPT</z:chebi>-11)+Bmab administration </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> of these chemotherapeutic treatments were administered on an outpatient basis </plain></SENT>
<SENT sid="7" pm="."><plain>Sixteen months after the diagnosis of <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e>, the patient died </plain></SENT>
<SENT sid="8" pm="."><plain>In recent years, combination chemotherapy for unresectable <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> has become recognized as a standard regimen, though adverse effects frequently occur </plain></SENT>
<SENT sid="9" pm="."><plain>Thus, intensive chemotherapy is not always recommended for patients with poor PS </plain></SENT>
<SENT sid="10" pm="."><plain>In this report, we presented a case of <z:e sem="disease" ids="C0153676" disease_type="Neoplastic Process" abbrv="">pulmonary metastases</z:e> from <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e>, carcinomatous lymphangiosis, and sternum <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> that was successfully treated with mFOLFOX6+Bmab </plain></SENT>
</text></document>